HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm ischemia time and by using IGL-1 cold preservation solution.

Abstract
Organs from donors after controlled circulatory death (DCD III) exhibit a higher risk for graft dysfunction due to an initial period of warm ischemia. This procurement condition can also affect the yield of beta cells in islet isolates from donor pancreases, and hence their use for transplantation. The present study uses data collected and generated by our Beta Cell Bank to compare the number of beta cells in isolates from DCD III (n = 141) with that from donors after brain death (DBD, n = 609), before and after culture, and examines the influence of donor and procurement variables. Beta cell number per DCD III-organ was significantly lower (58 x 106 versus 84 x 106 beta cells per DBD-organ; p < 0.001) but their purity (24% insulin positive cells) and insulin content (17 μg / 106 beta cells in DCD III-organs versus 19 μg / 106 beta cells in DBD-organs) were similar. Beta cell number correlated negatively with duration of acirculatory warm ischemia time above 10 min; for shorter acirculatory warm ischemia time, DCD III-organs did not exhibit a lower beta cell yield (74 x 106 beta cells). Use of Institut Georges Lopez-1 cold preservation solution instead of University of Wisconsin solution or histidine-tryptophan-ketoglutarate also protected against the loss in beta cell yield from DCD III-organs (86 x 106 for IGL-1 versus 54 x 106 and 65 x 106 beta cells respectively, p = 0.042). Multivariate analysis indicates that both limitation of acirculatory warm ischemia time and use of IGL-1 prevent the reduced beta cell yield in islet cell isolates from DCD III-organs.
AuthorsDiedert L De Paep, Freya Van Hulle, Zhidong Ling, Marian Vanhoeij, Jacques Pirenne, Bart Keymeulen, Daniel Pipeleers, Daniel Jacobs-Tulleneers-Thevissen
JournalPloS one (PLoS One) Vol. 16 Issue 5 Pg. e0251055 ( 2021) ISSN: 1932-6203 [Electronic] United States
PMID33939760 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glutarates
  • IGL-1 solution
  • Insulin
  • Organ Preservation Solutions
  • University of Wisconsin-lactobionate solution
  • Histidine
  • Allopurinol
  • Tryptophan
  • Glutathione
  • Adenosine
  • Raffinose
Topics
  • Adenosine (metabolism, physiology)
  • Adult
  • Allopurinol (metabolism)
  • Brain Death (metabolism, pathology)
  • Female
  • Glutarates (metabolism)
  • Glutathione (metabolism, physiology)
  • Graft Survival (physiology)
  • Histidine (metabolism)
  • Humans
  • Insulin (metabolism, physiology)
  • Insulin-Secreting Cells (metabolism, physiology)
  • Liver Transplantation (methods)
  • Male
  • Middle Aged
  • Organ Preservation Solutions (metabolism)
  • Raffinose (metabolism, physiology)
  • Tissue Donors
  • Tissue and Organ Procurement (methods)
  • Tryptophan (metabolism)
  • Warm Ischemia (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: